1. Home
  2. GT vs GLPG Comparison

GT vs GLPG Comparison

Compare GT & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Goodyear Tire & Rubber Company

GT

The Goodyear Tire & Rubber Company

HOLD

Current Price

$6.77

Market Cap

1.8B

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$29.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GT
GLPG
Founded
1898
1999
Country
United States
Belgium
Employees
N/A
704
Industry
Automotive Aftermarket
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
GT
GLPG
Price
$6.77
$29.12
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$10.56
$36.50
AVG Volume (30 Days)
7.1M
185.9K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,280,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.14
$24.31
52 Week High
$12.03
$37.78

Technical Indicators

Market Signals
Indicator
GT
GLPG
Relative Strength Index (RSI) 43.06 39.44
Support Level $6.64 $28.78
Resistance Level $7.33 $34.04
Average True Range (ATR) 0.23 0.72
MACD 0.11 0.04
Stochastic Oscillator 54.49 45.60

Price Performance

Historical Comparison
GT
GLPG

About GT The Goodyear Tire & Rubber Company

Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific. The majority of its revenue is generated from the Americas business, which develops, manufactures, distributes, and sells tires and related products and services in North, Central, and South America, along with selling tires to various export markets, mainly through intersegment sales.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: